Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study
Van Eys, J.; Chen, T.; Moore, T.; Cheek, W.; Sexauer, C.; Starling, K.
Cancer Treatment Reports 65(7-8): 681-684
1981
ISSN/ISBN: 0361-5960 PMID: 7248985 Document Number: 177619
In a prospective, randomized, cooperative group trial, the value of iv vincristine and intrathecal methotrexate and hydrocortisone as adjuvant therapy to radiotherapy in children with medulloblastoma and ependymoma was evaluated. The data showed no improvement in the survival of such children when adjuvant therapy was given.
Document emailed within 1 workday
Related Documents
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740Curry, S.L.; Blessing, J.A.; Disaia, P.J.; Soper, J.T.; Twiggs, L.B. 1989: A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study Obstetrics and Gynecology 73(3 Pt 1): 357-362
McCracken, J.D.; Janaki, L.M.; Taylor, S.B.; Giri, P.G.; Weiss, G.B.; Gordon, W.; Vance, R.B.; Crowley, J. 1986: Concurrent chemotherapy and radiotherapy for limited small-cell carcinoma of the lung: a Southwest Oncology Group Study Seminars in Oncology 13(3 Suppl 3: 31-36
Livingston, R.B.; Helibrun, L.; Lehane, D.; Costanzi, J.J.; Bottomley, R.; Palmer, R.L.; Stuckey, W.J.; Hoogstraten, B. 1977: Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study Cancer Treatment Reports 61(9): 1623-1629
Leichman, L.; Steiger, Z.; Seydel, H.G.; Vaitkevicius, V.K. 1984: Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience Seminars in Oncology 11(2): 178-185
Eisenach, J.C.; Gebhart, G.F. 1995: Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats Anesthesiology 83(5): 1036-1045
Head, D.R.; Kopecky, K.J.; Willman, C.; Appelbaum, F.R. 1994: Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience Leukemia 8(Suppl): S38-S41
Nelson, R.W.; Frank, J.T. 1981: Intrathecal methotrexate-induced neurotoxicities American Journal of Hospital Pharmacy 38(1): 65-68
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456
Blatt, J.; Howrie, D.L.; Wollman, M.R.; Phebus, C.; Mirro, J. 1993: Toxicity following concurrent intrathecal and moderate-dose intravenous methotrexate Leukemia 7(11): 1734-1737
Pongudom, S.; Chinthammitr, Y. 2011: Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature Journal of the Medical Association of Thailand 94 Suppl. 1: S258-S263
Hilgers, R.D.; Von Hoff, D.D.; Stephens, R.L.; Boutselis, J.G.; Rivkin, S.E. 1985: Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study Cancer Treatment Reports 69(11): 1329-1330
Ramu, A.; Fusner, J.E. 1979: A pharmacokinetic model for predicting the concentration of methotrexate in plasma subsequent to intrathecal injection Israel Journal of Medical Sciences 15(6): 494-499
Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22
Oishi, N.; Berenberg, J.; Blumenstein, B.A.; Johnson, K.; Rivkin, S.E.; Bukowski, R.M.; O'Bryan, R.M.; Stephens, R.L.; Quagliana, J.; Saiers, J.H. 1987: Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1307-1308
Bernáldez-Ríos, R.; Villasís-Keever, M.A.; Beltrán-Adame, G.; García-Ramírez, R.; Rodríguez-Zepeda, M.C.; Hermida-Gutiérrez, I.; Arias-Gómez, J.; Cruz-Luna, E. 1998: Neurological and psychological sequelae in children with acute lymphoblastic leukemia who had received radiotherapy and intrathecal methotrexate Gaceta Medica de Mexico 134(2): 153-159
Leblanc, T.; Chevallier, B.; Doz, F.; Wood, C.; Lagardère, B.; Bastian, G.; Ladjabi, A. 1987: Inadvertent intrathecal injection of a high dose of methotrexate. Proposal of a therapeutic plan apropos of a case Annales de Pediatrie 34(6): 453-454
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688